Kaletra Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial
Condition:   COVID-19 Intervention:   Drug: Lopinavir/ritonavir Sponsors:   Sunnybrook Health Sciences Centre;   AbbVie Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2020 Category: Research Source Type: clinical trials

Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial
Condition:   COVID-19 Intervention:   Drug: Lopinavir/ritonavir Sponsors:   Sunnybrook Health Sciences Centre;   AbbVie Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2020 Category: Research Source Type: clinical trials

Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial)
Condition:   SARS-CoV-2 Infection Interventions:   Drug: lopinavir/ritonavir;   Drug: Hydroxychloroquine Sulfate;   Drug: Losartan;   Drug: Placebos Sponsor:   Bassett Healthcare Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2020 Category: Research Source Type: clinical trials

COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2
Condition:   SARS-CoV-2 Infection Interventions:   Drug: lopinavir/ritonavir;   Drug: Hydroxychloroquine Sulfate;   Drug: Losartan;   Drug: Placebos Sponsor:   Bassett Healthcare Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2020 Category: Research Source Type: clinical trials

Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial)
Condition:   SARS-CoV-2 Infection Interventions:   Drug: lopinavir/ritonavir;   Drug: Hydroxychloroquine Sulfate;   Drug: Losartan;   Drug: Placebos Sponsor:   Bassett Healthcare Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2020 Category: Research Source Type: clinical trials

COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2
Condition:   SARS-CoV-2 Infection Interventions:   Drug: lopinavir/ritonavir;   Drug: Hydroxychloroquine Sulfate;   Drug: Losartan;   Drug: Placebos Sponsor:   Bassett Healthcare Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2020 Category: Research Source Type: clinical trials

Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 In a Pragmatic aDaptive randoMizED Clinical Trial During the COVID-19 Pandemic (COVID MED Trial)
Condition:   SARS-CoV-2 Infection Interventions:   Drug: lopinavir/ritonavir;   Drug: Hydroxychloroquine Sulfate;   Drug: Losartan;   Drug: Placebos Sponsor:   Bassett Healthcare Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2020 Category: Research Source Type: clinical trials

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
Condition:   COVID-19 Interventions:   Drug: Lopinavir/ritonavir;   Drug: Hydroxychloroquine sulfate;   Drug: Baricitinib (janus kinase inhibitor);   Drug: Sarilumab (anti-IL-6 receptor) Sponsors:   Lisa Barrett;   Nova Scotia Health Authority;   Dalhousie University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2020 Category: Research Source Type: clinical trials